None listed
Conditions
Interventions
Others(Human tissue ) : In the Aesten Inject® injection experimental treatment group, the participants will be positioned in the supine position. An ultrasound probe will be placed on the medial side
Sponsors
Inje University Busan Paik Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Adults aged 19 to 50 years, both male and female 2)Patients within 48 hours of injury with no previous history of the same ankle sprain 3)Patients with Grade II partial tear of the anterior talofibular ligament confirmed by ultrasound 4)Patients willing to participate in the clinical trial, comply with the treatment and procedures, and visit the hospital for all follow-up assessments 5)Patients who have listened to an explanation about the purpose, methods, and potential effects of the clinical trial and voluntarily signed the informed consent form
Exclusion criteria
Exclusion criteria: 1)Patients with a history of injections or physical therapy treatments on the same ankle 2)Patients with serious underlying conditions (e.g., cancer, kidney disease, liver disease, neurological disorders, bleeding disorders, dementia) 3)Patients with motor or sensory impairments in the affected limb due to neurological disorders 4)Pregnant or breastfeeding patients 5)Patients whom the investigator deems unsuitable for participation in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Active range of motion | — |
Secondary
| Measure | Time frame |
|---|---|
| VAS(Visual Analogue Scale) ;FAOS (Foot and Ankle Outcome Score);all adverse events | — |
Countries
Korea, Republic of
Contacts
Public ContactDae-Yoo Kim
Inje University Busan Paik Hospital
Outcome results
None listed